Hang Yuan

Hang Yuan is an accomplished professional with extensive experience in process development and biotechnology. Currently serving as Chief Technical Officer and Co-founder at Innovac Therapeutics since May 2022, Hang previously held the position of Vice President of Process Development at BlueRock Therapeutics from September 2020 to May 2022. Prior roles include Senior Director of Biologics Process Development at both Takeda and Shire, as well as positions at Biogen Idec and Pfizer Pharmaceuticals, where expertise in bio-process development was honed. Hang's academic background includes a PhD in Chemical Engineering from Florida State University, a Master of Arts in Management from Harvard Extension School, and a BS in Biochemical Engineering from East China University of Science and Technology.